2010•Zhonghua zhongliu fangzhi zazhiRequires access

Three-dimensional conformal radiotherapy combined with concurrent chemotherapy for locally advanced esophageal carcinoma

Chao Gao

Open publisher page 1 citations

Abstract

OBJECTIVE:To observe the acute side effects and clinical results of three-dimensional conformal radiotherapy(3DCRT) combined with chemotherapy for esophageal carcinoma.METHODS:Totally 62 patients with esophageal carcinoma received 3DCRT combined with concurrent chemotherapy of LFP.The side effects and clinical results were observed.RESULTS:1) Of all the patients,61 completed radiotherapy,29 patients completed 3 or more than 3 cycles of chemotherapy,18 completed 2 cycles and 15 completed only 1 cycle.2) The acute toxic reactions were marrow depression and gastrointestinal tract reaction mainly,49(79.03%) patients developed the side effects of nausea,vomiting and constipation,and the incidence of leucopenia was 80.65%(50/62).Fifty patients(80.65%) developed acute radiation esophagitis with 88.00%(44/50) of grade 1 and grade 2,and 24 patients(38.71%) developed acute radiation pneumonitis with 54.17%(13/24)of grade 1.3)The 1-,2-,3-year local control rates were 89.97%,70.66% and 70.66%,respectively.The 1-,2-,3-year overall survival rates were 88.33%,55.78% and 52.68%,respectively,and the median survival time was 28 months.For the patients whose maximum trans diameter of GTV was less and more than 4 cm,the 1-,2-,3-year survival rates were 96.88%,74.27%,68.08% and 78.57%,34.83% and 34.83%,respectively(χ2=7.48,P=0.006 2).CONCLUSIONS:3DCRT combined with concurrent chemotherapy of LFP has its feasibility and the majority of patients could tolerate the treatment.This pattern of treatment could make well local control rate and survival rate,and the clinic effect has the potential of improvement,but the control of metastasis has no improvement.

About this research paper

What this paper is about

OBJECTIVE:To observe the acute side effects and clinical results of three-dimensional conformal radiotherapy(3DCRT) combined with chemotherapy for esophageal carcinoma.METHODS:Totally 62 patients with esophageal carcinoma received 3DCRT combined with concurrent chemotherapy of LFP.The side effects and clinical results were observed.RESULTS:1) Of all the patients,61 completed radiotherapy,29 patients completed 3 or more than 3 cycles of chemotherapy,18 completed 2 cycles and 15 completed only 1 cycle.2) The acute toxic reactions were marrow depression and gastrointestinal tract reaction mainly,49(79.03%) patients developed the side effects of nausea,vomiting and constipation,and the incidence of leucopenia was 80.65%(50/62).Fifty patients(80.65%) developed acute radiation esophagitis with 88.00%(44/50) of grade 1 and grade 2,and 24 patients(38.71%) developed acute radiation pneumonitis with 54.17%(13/24)of grade 1.3)The 1-,2-,3-year local control rates were 89.97%,70.66% and 70.66%,respectively.The 1-,2-,3-year overall survival rates were 88.33%,55.78% and 52.68%,respectively,and the median survival time was 28 months.For the patients whose maximum trans diameter of GTV was less and more than 4 cm,the 1-,2-,3-year survival rates were 96.88%,74.27%,68.08% and 78.57%,34.83% and 34.83%,respectively(χ2=7.48,P=0.006 2).CONCLUSIONS:3DCRT combined with concurrent chemotherapy of LFP has its feasibility and the majority of patients could tolerate the treatment.This pattern of treatment could make well local control rate and survival rate,and the clinic effect has the potential of improvement,but the control of metastasis has no improvement.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To observe the acute side effects and clinical results of three-dimensional conformal radiotherapy(3DCRT) combined with chemotherapy for esophageal carcinoma.METHODS:Totally 62 patients with esophageal carcinoma received 3DCRT combined with concurrent chemotherapy of LFP.The side effects and clinical results were observed.RESULTS:1) Of all the patients,61 completed radiotherapy,29 patients completed 3 or more than 3 cycles of chemotherapy,18 completed 2 cycles and 15 completed only 1 cycle.2) The acute toxic reactions were marrow depression and gastrointestinal tract reaction mainly,49(79.03%) patients developed the side effects of nausea,vomiting and constipation,and the incidence of leucopenia was 80.65%(50/62).Fifty patients(80.65%) developed acute radiation esophagitis with 88.00%(44/50) of grade 1 and grade 2,and 24 patients(38.71%) developed acute radiation pneumonitis with 54.17%(13/24)of grade 1.3)The 1-,2-,3-year local control rates were 89.97%,70.66% and 70.66%,respectively.The 1-,2-,3-year overall survival rates were 88.33%,55.78% and 52.68%,respectively,and the median survival time was 28 months.For the patients whose maximum trans diameter of GTV was less and more than 4 cm,the 1-,2-,3-year survival rates were 96.88%,74.27%,68.08% and 78.57%,34.83% and 34.83%,respectively(χ2=7.48,P=0.006 2).CONCLUSIONS:3DCRT combined with concurrent chemotherapy of LFP has its feasibility and the majority of patients could tolerate the treatment.This pattern of treatment could make well local control rate and survival rate,and the clinic effect has the potential of improvement,but the control of metastasis has no improvement.

Key concepts: Medicine, Nausea, Vomiting, Chemotherapy, Gastroenterology, Internal medicine, Esophagitis, Radiation therapy

Related papers

Back to paper searchBrowse research topicsOriginal source
Three-dimensional conformal radiotherapy combined with concurrent chemotherapy for locally advanced esophageal carcinoma — Research Paper | ScholarLens